These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 28082802)

  • 1. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
    Buanes TA
    World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of surgery in pancreatic cancer.
    Buanes TA
    World J Gastroenterol; 2017 Jun; 23(21):3765-3770. PubMed ID: 28638216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current standards and new innovative approaches for treatment of pancreatic cancer.
    Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
    Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
    Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
    Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D; Gustafsson A; Andersson R
    World J Gastroenterol; 2015 Mar; 21(11):3157-65. PubMed ID: 25805920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
    Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
    Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Clin Transl Oncol; 2012 May; 14(5):391-5. PubMed ID: 22551547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma of the ampulla of Vater: what treatment options are available?
    Senatore FJ; Ynson ML; Dasanu CA
    J Oncol Pharm Pract; 2015 Oct; 21(5):364-9. PubMed ID: 24906539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.
    Hoffman JP; Cooper HS; Young NA; Pendurthi TK
    J Hepatobiliary Pancreat Surg; 1998; 5(3):251-4. PubMed ID: 9880771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer-improved care achievable.
    Buanes TA
    World J Gastroenterol; 2014 Aug; 20(30):10405-18. PubMed ID: 25132756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.
    Erdmann JI; Eskens FA; Vollmer CM; Kok NF; Groot Koerkamp B; Biermann K; van Eijck CH
    Ann Surg Oncol; 2015 Jul; 22(7):2401-7. PubMed ID: 25503345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients.
    Baghmar S; Agrawal N; Kumar G; Bihari C; Patidar Y; Kumar S; Chattopadhyay TK; Panda D; Arora A; Pamecha V
    J Gastrointest Cancer; 2019 Sep; 50(3):361-369. PubMed ID: 29464529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue.
    Booy S; Hofland LJ; Waaijers AM; Croze E; van Koetsveld PM; de Vogel L; Biermann K; van Eijck CH
    Pancreas; 2015 Jan; 44(1):99-105. PubMed ID: 25072284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of a patient with borderline resectable pancreatic cancer. Case report and review.
    Shah AP; Strauss JB; Leslie WT; Shah A; Mahon B; Abrams RA
    Oncology (Williston Park); 2008 Nov; 22(13):1524-9. PubMed ID: 19133606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
    Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
    Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.
    Erdmann JI; Morak MJ; Duivenvoorden HJ; van Dekken H; Kazemier G; Kok NF; van Eijck CH
    HPB (Oxford); 2015 Jul; 17(7):573-9. PubMed ID: 25800041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Approach to Adenocarcinoma of the Ampulla of Vater.
    Patel M; Uboha NV
    Curr Treat Options Oncol; 2021 Sep; 22(11):103. PubMed ID: 34586537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.
    Ramfidis VS; Syrigos KN; Saif MW
    JOP; 2013 Mar; 14(2):158-60. PubMed ID: 23474562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891.
    Smeenk HG; van Eijck CH; Hop WC; Erdmann J; Tran KC; Debois M; van Cutsem E; van Dekken H; Klinkenbijl JH; Jeekel J
    Ann Surg; 2007 Nov; 246(5):734-40. PubMed ID: 17968163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.